Request Sample Inquiry
Vaccines Market

Vaccines Market

Vaccines Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

141

Base Year:

2022

Date

Apr - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1508

Segments Covered
  • By Technology (excluding COVID 19 vaccines) By Technology (excluding COVID 19 vaccines) Conjugate vaccines, Inactivated & Subunit vaccines, Live Attenuated vaccines, Recombinant vaccines, Toxoid vaccines, Viral vector vaccines
  • By Technology (including COVID 19 vaccines) By Technology (including COVID 19 vaccines) mRNA vaccines, Viral Vector vaccines, Others
  • By Type By Type Monovalent vaccines, Multivalent vaccines
  • By Disease Indication By Disease Indication Influenza, Pneumococcal diseases, Combination vaccines, HPV, Herpes Zoster, Meningococcal diseases, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, COVID 19, Others
  • By Route of Administration By Route of Administration Intramuscular & Subcutaneous administration, Oral administration, Others
  • By End-user By End-user Pediatric vaccines, Adult vaccines
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 43.80 Billion
Revenue 2030Revenue 2030: USD 90.52 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 9.50%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Research Methodology: Vaccines Market by Technology (excluding COVID 19 vaccines) by Technology (including COVID 19 vaccines) by Type by Disease Indication by Route of Administration by End-user by Region - Global Market Assessment, 2021 - 2028

Secondary Research

Primary Research:

Data Triangulation and Market Size Estimations

FAQ
Frequently Asked Question
  • The global Vaccines valued at USD 43.80 Billion in 2022 and is expected to reach USD 90.52 Billion in 2030 growing at a CAGR of 9.50%.

  • The prominent players in the market are GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), Pfizer Inc. (US), Sanofi SA (France), CSL Limited (Australia), Emergent BioSolutions Inc. (US), Johnson & Johnson (US), AstraZeneca plc (UK), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic A/S (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo Company, Limited (Japan), Panacea Biotec, Ltd. (India), Biological E Limited (India), Bharat Biotech Ltd. (India), Novavax Inc. (US), FSUE NPO Microgen (Russia), Sinovac Biotech, Ltd. (China), Incepta Vaccine Limited (Bangladesh), Valneva SE (France), VBI Vaccines (US), PT Bio Farma (Persero) (Indonesia), Inovio Pharmaceuticals Inc. (US), Chongqing Zhifei Biological Products Co., Ltd. (China), Indian Immunologicals Limited (India)..

  • The market is project to grow at a CAGR of 9.50% between 2023 and 2030.

  • The driving factors of the Vaccines include

    • Growing prevalence of emerging and re-emerging infectious diseases

  • North America was the leading regional segment of the Vaccines in 2022.